Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru

被引：49
作者：
Abugattas, J. [1 ]
Llacuachaqui, M. [2 ]
Allende, Y. Sullcahuaman [3 ,4 ]
Velasquez, A. Arias [3 ]
Velarde, R. [1 ]
Cotrina, J. [1 ]
Garces, M. [1 ]
Leon, M. [1 ]
Calderon, G. [1 ]
de la Cruz, M. [1 ]
Mora, P. [1 ]
Royer, R. [2 ]
Herzog, J. [5 ,6 ]
Weitzel, J. N. [5 ,6 ]
Narod, S. A. [2 ]
机构：
[1] Inst Nacl Enfermedades Neoplas, Dept Mamas Partes Blandas & Piel, Lima, Peru
[2] Womens Coll Res Inst, Familial Breast Canc Res Unit, Toronto, ON, Canada
[3] Inst Nacl Enfermedades Neoplas, Unidad Genet & Biol Mol, Lima, Peru
[4] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru
[5] City Hope Natl Med Ctr, Comprehens Canc Ctr, Duarte, CA USA
[6] City Hope Natl Med Ctr, Beckman Res Inst, Div Clin Canc Genet, Duarte, CA 91010 USA
来源：
CLINICAL GENETICS | 2015年 / 88卷 / 04期
关键词：
Peru; breast cancer; hereditary; BRCA1; BRCA2; BREAST/OVARIAN CANCER; FAMILY-HISTORY; RISKS; ASSOCIATION; WOMEN;
D O I：
10.1111/cge.12505
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
The prevalence of BRCA1 and BRCA2 mutations among breast cancer patients in Peru has not yet been explored. We enrolled 266 women with breast cancer from a National cancer hospital in Lima, Peru, unselected for age or family history. DNA was screened with a panel of 114 recurrent Hispanic BRCA mutations (HISPANEL). Among the 266 cases, 13 deleterious mutations were identified (11 in BRCA1 and 2 in BRCA2), representing 5% of the total. The average age of breast cancer in the mutation-positive cases was 44 years. BRCA1 185delAG represented 7 of 11 mutations in BRCA1. Other mutations detected in BRCA1 included: two 2080delA, one 943ins10, and one 3878delTA. The BRCA2 3036del4 mutation was seen in two patients. Given the relatively low cost of the HISPANEL test, one should consider offering this test to all Peruvian women with breast or ovarian cancer.
引用
收藏
页码：371 / 375
页数：5
相关论文
共 34 条
  • [1] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
    Antoniou, A
    Pharoah, PDP
    Narod, S
    Risch, HA
    Eyfjord, JE
    Hopper, JL
    Loman, N
    Olsson, H
    Johannsson, O
    Borg, Å
    Pasini, B
    Radice, P
    Manoukian, S
    Eccles, DM
    Tang, N
    Olah, E
    Anton-Culver, H
    Warner, E
    Lubinski, J
    Gronwald, J
    Gorski, B
    Tulinius, H
    Thorlacius, S
    Eerola, H
    Nevanlinna, H
    Syrjäkoski, K
    Kallioniemi, OP
    Thompson, D
    Evans, C
    Peto, J
    Lalloo, F
    Evans, DG
    Easton, DF
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) : 1117 - 1130
  • [2] Breast Cancer Information Core (BIC), 2010, OP ACC ONL BREAST CA
  • [3] BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants
    Delgado, L.
    Fernandez, G.
    Grotiuz, G.
    Cataldi, S.
    Gonzalez, A.
    LLuveras, N.
    Heguaburu, M.
    Fresco, R.
    Lens, D.
    Sabini, G.
    Muse, I. M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (01) : 211 - 218
  • [4] Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
    Domchek, Susan M.
    Friebel, Tara M.
    Singer, Christian F.
    Evans, D. Gareth
    Lynch, Henry T.
    Isaacs, Claudine
    Garber, Judy E.
    Neuhausen, Susan L.
    Matloff, Ellen
    Eeles, Rosalind
    Pichert, Gabriella
    Van T'veer, Laura
    Tung, Nadine
    Weitzel, Jeffrey N.
    Couch, Fergus J.
    Rubinstein, Wendy S.
    Ganz, Patricia A.
    Daly, Mary B.
    Olopade, Olufunmilayo I.
    Tomlinson, Gail
    Schildkraut, Joellen
    Blum, Joanne L.
    Rebbeck, Timothy R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (09): : 967 - 975
  • [5] A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
    Donenberg, Talia
    Lunn, John
    Curling, DuVaughn
    Turnquest, Theodore
    Krill-Jackson, Elisa
    Royer, Robert
    Narod, Steven A.
    Hurley, Judith
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 591 - 596
  • [6] Genome-wide association study identifies novel breast cancer susceptibility loci
    Easton, Douglas F.
    Pooley, Karen A.
    Dunning, Alison M.
    Pharoah, Paul D. P.
    Thompson, Deborah
    Ballinger, Dennis G.
    Struewing, Jeffery P.
    Morrison, Jonathan
    Field, Helen
    Luben, Robert
    Wareham, Nicholas
    Ahmed, Shahana
    Healey, Catherine S.
    Bowman, Richard
    Meyer, Kerstin B.
    Haiman, Christopher A.
    Kolonel, Laurence K.
    Henderson, Brian E.
    Le Marchand, Loic
    Brennan, Paul
    Sangrajrang, Suleeporn
    Gaborieau, Valerie
    Odefrey, Fabrice
    Shen, Chen-Yang
    Wu, Pei-Ei
    Wang, Hui-Chun
    Eccles, Diana
    Evans, D. Gareth
    Peto, Julian
    Fletcher, Olivia
    Johnson, Nichola
    Seal, Sheila
    Stratton, Michael R.
    Rahman, Nazneen
    Chenevix-Trench, Georgia
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Axelsson, Christen K.
    Garcia-Closas, Montserrat
    Brinton, Louise
    Chanock, Stephen
    Lissowska, Jolanta
    Peplonska, Beata
    Nevanlinna, Heli
    Fagerholm, Rainer
    Eerola, Hannaleena
    Kang, Daehee
    Yoo, Keun-Young
    Noh, Dong-Young
    Ahn, Sei-Hyun
    [J]. NATURE, 2007, 447 (7148) : 1087 - U7
  • [7] Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
    Finch, Amy P. M.
    Lubinski, Jan
    Moller, Pal
    Singer, Christian F.
    Karlan, Beth
    Senter, Leigha
    Rosen, Barry
    Maehle, Lovise
    Ghadirian, Parviz
    Cybulski, Cezary
    Huzarski, Tomasz
    Eisen, Andrea
    Foulkes, William D.
    Kim-Sing, Charmaine
    Ainsworth, Peter
    Tung, Nadine
    Lynch, Henry T.
    Neuhausen, Susan
    Metcalfe, Kelly A.
    Thompson, Islay
    Murphy, Joan
    Sun, Ping
    Narod, Steven A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15) : 1547 - U43
  • [8] RISKS OF CANCER IN BRCA1-MUTATION CARRIERS
    FORD, D
    EASTON, DF
    BISHOP, DT
    NAROD, SA
    GOLDGAR, DE
    HAITES, N
    MILNER, B
    ALLAN, L
    PONDER, BAJ
    PETO, J
    SMITH, S
    STRATTON, M
    LENOIR, GM
    FEUNTEUN, J
    LYNCH, H
    ARASON, A
    BARKARDOTTIR, R
    EGILSSON, V
    BLACK, DM
    KELSELL, D
    SPURR, N
    DEVILEE, P
    CORNELISSE, CJ
    VARSEN, H
    BIRCH, JM
    SKOLNICK, M
    SANTIBANEZKOREF, MS
    TEARE, D
    STEEL, M
    PORTER, D
    COHEN, BB
    CAROTHERS, A
    SMYTH, E
    WEBER, B
    NEWBOLD, B
    BOEHNKE, M
    COLLINS, FS
    CANNONALBRIGHT, LA
    GOLDGAR, D
    [J]. LANCET, 1994, 343 (8899) : 692 - 695
  • [9] Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations
    Gallardo, M
    Silva, A
    Rubio, L
    Alvarez, C
    Torrealba, C
    Salinas, M
    Tapia, T
    Faundez, P
    Palma, L
    Riccio, M
    Paredes, H
    Rodriguez, M
    Cruz, A
    Rousseau, C
    King, M
    Camus, M
    Alvarez, M
    Carvallo, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 95 (01) : 81 - 87
  • [10] Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
    Gomes, Magda C. B.
    Costa, Mauricio M.
    Borojevic, Radovan
    Monteiro, Alvaro N. A.
    Vieira, Roberto
    Koifman, Sergio
    Koifman, Rosalina Jorge
    Li, Song
    Royer, Robert
    Zhang, Shiyu
    Narod, Steven A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (03) : 349 - 353
1234